C5L2/GPR77 Antibody (650918) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10254JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2B Clone # 650918
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human C5L2/GPR77
Met1-Val337
Accession # Q9P296
Met1-Val337
Accession # Q9P296
Specificity
Detects human C5L2/GPR77 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for C5L2/GPR77 Antibody (650918) [Janelia Fluor® 669]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: C5L2/GPR77
Long Name
C5a Anaphylatoxin Chemotactic Receptor C5L2
Alternate Names
GPR77
Additional C5L2/GPR77 Products
Product Documents for C5L2/GPR77 Antibody (650918) [Janelia Fluor® 669]
Product Specific Notices for C5L2/GPR77 Antibody (650918) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...